PreveCeutical Medical Inc.
PREV
CNSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -204.75% | 44.50% | -37.77% | -54.14% | 38.04% |
| Total Depreciation and Amortization | 15.79% | 0.00% | 5.56% | 0.00% | 5.56% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 152.05% | 19.57% | 4.08% | -8.96% | -47.54% |
| Change in Net Operating Assets | 337.15% | -91.32% | 24.03% | 229.15% | -27.53% |
| Cash from Operations | -67.90% | -72.53% | -126.87% | -61.41% | 38.67% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -6,566.67% | -- | -- | -104.17% | 75.00% |
| Total Debt Issued | -2.48% | 123.66% | -53.09% | 44.44% | -39.54% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 69.42% | 228.57% | 126.52% | 72.51% | -39.30% |
| Foreign Exchange rate Adjustments | -600.00% | 50.00% | 114.29% | -250.00% | 120.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3,840.00% | 21,150.00% | 100.00% | 29.63% | 233.33% |